Download PDF

Other users also viewed these articles

Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them S. Marciano; M. Dirchwolf; M.C. Torres; J. Allevato; C. García Dans; B. García; F. Pollarsky; L. Gaite; E. Sirotinsky; B. Rios; M.N. Anselmo; M. Peche; E. Hurtado; L. Haddad; A. Narvaez; E. Mauro; A. Martinez; C. Bellizzi; N. Ratusnu; C. D¿Amico; S. Arora; A. Gadano;
Rev Gastroenterol Mex. 2022;87:4-12
Evaluation of fibrosis in patients with nonalcoholic fatty liver disease Aldo J. Montaño-Loza;
Rev Gastroenterol Mex. 2022;87:1-3
Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study R. Bernal-Reyes; M.E. Icaza-Chávez; L.A. Chi-Cervera; J.M. Remes-Troche; M. Amieva-Balmori; B.A. Priego-Parra; S. Martínez-Vázquez; I.O. Méndez-Guerrero; L. Martínez-Rodríguez; A. Barranca-Enríquez; C. Palmeros-Exsome; A.D. Cano-Contreras; A. Triana-Romero;
Rev Gastroenterol Mex. 2023;88:199-207